# Cromolyn Sodium for Treatment of COVID-19 Pneumonia

> **NCT05077917** · PHASE3 · TERMINATED · sponsor: **Texas Tech University Health Sciences Center, El Paso** · enrollment: 22 (actual)

## Conditions studied

- COVID-19 Pneumonia
- COVID-19 Respiratory Infection
- Pneumonia, Viral

## Interventions

- **DRUG:** Cromolyn Sodium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05077917
- **Lead sponsor:** Texas Tech University Health Sciences Center, El Paso
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-15
- **Primary completion:** 2024-05-23
- **Final completion:** 2024-05-23
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077917, "Cromolyn Sodium for Treatment of COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05077917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*